Autopsy report · NCT02844712

Negative Predictive Value of Drug Provocation Tests to Beta-lactams

“End of the period of inclusion, NSN not achieved”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 7 months after it had already started.
• Ran for about 1 year 11 months before it stopped.
• 750 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University Hospital, Montpellier

Sponsor type

University, hospital or other

Conditions

Drug Hypersensitivity

Interventions

Evaluation of reexposure to a negatively tested betalactam

Participants

750

Sites

1

Countries

France

Trials that died the same way

• Study of the Visual Perception During Emotional States on Subjects With an Intrusive Disorder of the Development
  “end of inclusion period” (66% match in meaning)
• EXOme Rare Cancers in Children (EXOCARE)
  “Inclusions stopped due to lack of inclusions” (58% match in meaning)
• Neurophysiological Validation of the Clinical Criteria of Sensitization in Chronic Pelvic and Perineal Pain Population
  “End of inclusions” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.